https://www.selleckchem.com/products/blu-554.html
Introduction Infections in hematological cancer patients are common and usually life-threatening; avoiding them could decrease morbidity, mortality, and cost. Genes associated with antineoplastics' pharmacokinetics or with the immune/inflammatory response could explain variability in infection occurrence. Objective To build a pharmacogenetic-based algorithm to predict the incidence of infections in patients undergoing cytotoxic chemotherapy. Methods Prospective cohort study in adult patients receiving cytotoxic chemotherapy to treat leu
Like
Comment
Share
